PRA Health Sciences (PRAH) Scheduled to Post Earnings on Wednesday
PRA Health Sciences (NASDAQ:PRAH) will be issuing its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $0.95 per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.
Shares of NASDAQ:PRAH opened at $95.93 on Wednesday. PRA Health Sciences has a 52 week low of $79.20 and a 52 week high of $121.98. The company has a market capitalization of $6.18 billion, a price-to-earnings ratio of 24.41, a PEG ratio of 1.36 and a beta of 1.12. The company has a current ratio of 0.87, a quick ratio of 0.87 and a debt-to-equity ratio of 1.03.
PRAH has been the topic of several analyst reports. BidaskClub lowered shares of PRA Health Sciences from a “buy” rating to a “hold” rating in a research note on Thursday, December 27th. SunTrust Banks raised their price target on shares of PRA Health Sciences to $120.00 and gave the company an “average” rating in a research note on Monday, March 4th. ValuEngine upgraded shares of PRA Health Sciences from a “hold” rating to a “buy” rating in a report on Monday, February 4th. Robert W. Baird increased their price objective on shares of PRA Health Sciences from $119.00 to $122.00 and gave the company an “outperform” rating in a report on Thursday, February 28th. Finally, Zacks Investment Research cut shares of PRA Health Sciences from a “buy” rating to a “hold” rating in a report on Wednesday, January 2nd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $113.22.
About PRA Health Sciences
PRA Health Sciences, Inc, a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services.
Recommended Story: Do closed-end mutual funds pay dividends?
Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.